 Surgalign Holdings Inc NASDAQ: SRGA has priced its previously announced underwritten public offering of 43.47 million and warrants to purchase up to 32.6 million shares at a combined price of 0.46 per share. The gross proceeds are expected to be approximately 20 million. 